Cloud-based medical image analysis tech developer inHeart announced today that it closed a funding round worth $4.2 million (€3.7 million).
Pessac, France-based inHeart, which provides image analysis for cardiac interventions on patients with arrhythmias, said in a news release that the funding round, led by Elaia, will be used to accelerate commercial development in Europe, access the U.S. market and advance its technology leadership with the continued development of artificial intelligence tech and numerical simulations of cardiac electrical activity.
The inHeart software offers the ability to transform preoperative medical images into a 3D digital twin of the patient’s heart, enabling the cardiologist to better plan the procedure and assisting in navigating instruments in the patient’s heart, reducing procedure duration and failure rates.
“We are very happy to have Elaia joining inHEART in this adventure not only for its financial support but also for the dynamism and the expertise of its team in developing startups in healthcare,” inHeart CEO & co-founder Jean-Marc Peyrat said in the release. “Elaia and inHEART share the same ambition to create a major player in cardiac electrophysiology, a €5 billion market with healthcare giants such as Johnson & Johnson, Abbott, Boston Scientific or Medtronic.”
$1 = €0.890310
